FI106723B - Menetelmä nanopartikkelien valmistamiseksi - Google Patents

Menetelmä nanopartikkelien valmistamiseksi Download PDF

Info

Publication number
FI106723B
FI106723B FI935869A FI935869A FI106723B FI 106723 B FI106723 B FI 106723B FI 935869 A FI935869 A FI 935869A FI 935869 A FI935869 A FI 935869A FI 106723 B FI106723 B FI 106723B
Authority
FI
Finland
Prior art keywords
nanoparticles
polymer
copolymer
process according
solution
Prior art date
Application number
FI935869A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI935869A0 (fi
FI935869A (fi
Inventor
Homme Christian Prud
Gilles Spenlehauer
Didier Bazile
Michel Veillard
Jean-Paul Michalon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI935869A0 publication Critical patent/FI935869A0/fi
Publication of FI935869A publication Critical patent/FI935869A/fi
Application granted granted Critical
Publication of FI106723B publication Critical patent/FI106723B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/14—Powdering or granulating by precipitation from solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02—Polyalkylene oxides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Glass Compositions (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Rear-View Mirror Devices That Are Mounted On The Exterior Of The Vehicle (AREA)
FI935869A 1991-06-28 1993-12-27 Menetelmä nanopartikkelien valmistamiseksi FI106723B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9108042A FR2678178A1 (fr) 1991-06-28 1991-06-28 Procede de preparation de nanoparticules.
FR9108042 1991-06-28
FR9200582 1992-01-21
PCT/FR1992/000582 WO1993000388A1 (fr) 1991-06-28 1992-06-25 Procede de preparation de nanoparticules

Publications (3)

Publication Number Publication Date
FI935869A0 FI935869A0 (fi) 1993-12-27
FI935869A FI935869A (fi) 1993-12-27
FI106723B true FI106723B (fi) 2001-03-30

Family

ID=9414445

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935869A FI106723B (fi) 1991-06-28 1993-12-27 Menetelmä nanopartikkelien valmistamiseksi

Country Status (14)

Country Link
EP (2) EP0520889A1 (es)
JP (1) JP3228742B2 (es)
AT (1) ATE135385T1 (es)
CA (1) CA2102185C (es)
DE (1) DE69209074T2 (es)
DK (1) DK0591331T3 (es)
ES (1) ES2084363T3 (es)
FI (1) FI106723B (es)
FR (1) FR2678178A1 (es)
GR (1) GR3019308T3 (es)
IE (1) IE72509B1 (es)
MX (1) MX9203354A (es)
NO (1) NO308313B1 (es)
WO (1) WO1993000388A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
FR2721510B1 (fr) * 1994-06-22 1996-07-26 Rhone Poulenc Rorer Sa Nanoparticules filtrables dans des conditions stériles.
US6007845A (en) * 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
JPH11322948A (ja) * 1998-05-08 1999-11-26 Nof Corp 高分子微粒子およびその製造方法
DE19839212C2 (de) 1998-08-28 2002-05-23 Celanese Ventures Gmbh Verfahren zur Herstellung von sphärischen Nanopartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen linearen Polysaccharid bestehen
CA2309575A1 (en) * 2000-05-26 2001-11-26 James E. Guillet Internally cross-linked macromolecules
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
JP5398112B2 (ja) * 2005-10-27 2014-01-29 東レ株式会社 生分解性粒子およびその製造方法
FR2936722B1 (fr) * 2008-10-07 2013-11-22 Nanolege Inc Materiaux nanocomposites et procede de fabrication par nanoprecipitation.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules

Also Published As

Publication number Publication date
FI935869A0 (fi) 1993-12-27
NO934359L (no) 1993-12-01
DE69209074T2 (de) 1996-09-05
FI935869A (fi) 1993-12-27
ES2084363T3 (es) 1996-05-01
MX9203354A (es) 1992-12-01
FR2678178B1 (es) 1995-01-13
CA2102185A1 (fr) 1992-12-29
JP3228742B2 (ja) 2001-11-12
EP0591331B1 (fr) 1996-03-13
EP0520889A1 (fr) 1992-12-30
NO934359D0 (no) 1993-12-01
EP0591331A1 (fr) 1994-04-13
FR2678178A1 (fr) 1992-12-31
NO308313B1 (no) 2000-08-28
CA2102185C (fr) 2003-07-22
DE69209074D1 (de) 1996-04-18
DK0591331T3 (da) 1996-04-01
IE922109A1 (en) 1992-12-30
ATE135385T1 (de) 1996-03-15
GR3019308T3 (en) 1996-06-30
IE72509B1 (en) 1997-04-23
WO1993000388A1 (fr) 1993-01-07
JPH06508867A (ja) 1994-10-06

Similar Documents

Publication Publication Date Title
FI109576B (fi) Nanopartikkeleita, joilla on retikuloendoteelijärjestelmän toimesta pidentynyt sieppausaika
US5766635A (en) Process for preparing nanoparticles
FI106723B (fi) Menetelmä nanopartikkelien valmistamiseksi
KR100448170B1 (ko) 폴리에틸렌이민을 친수성 블록으로 갖고 폴리에스테르계고분자를 소수성 블록으로 갖는 양친성 생분해성 블록공중합체 및 이를 이용한 수용액 상에서의 고분자자기조합 회합체
JP3523821B2 (ja) 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
IE83404B1 (en) Polyethylene-polylactic acid block copolymer nanoparticles
US20040138095A1 (en) Colloidal suspension of nanoparticles based on an amphiphilic copolymer
Vandorpe et al. Long circulating biodegradable poly (phosphazene) nanoparticles surface modified with poly (phosphazene)-poly (ethylene oxide) copolymer
US8299178B2 (en) Stable micelles formed with diblock copolymers of critical micelle concentration copolymer and temperature-sensitive copolymer
SK26096A3 (en) Contrasting agent, method of manufacture thereof and application
EA036522B1 (ru) Фармацевтическая композиция, пригодная для лиофилизации, содержащая множество терапевтических частиц
PL173254B1 (pl) Środek farmaceutyczny w postaci koloidalnej zawiesiny nanokapsułek i sposób wytwarzania środka farmaceutycznego w postaci koloidalnej zawiesiny nanokapsułek
JP2000507934A (ja) 有効成分の担体として使用できる複合ゲル微粒子、その製造法、およびその使用
US20040048782A1 (en) Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same
US20100254939A1 (en) Graft copolymers as drug delivery systems
US20050043481A1 (en) Material consisting of at least a biodegradable polymer and cyclodextrins
Leiske et al. Mission ImPOxable–or the unknown utilization of non-toxic poly (2-oxazoline) s as cryoprotectants and surfactants at the same time
Jang et al. Characterization and modification of low molecular water-soluble chitosan for pharmaceutical application
CN106188550B (zh) 树枝状嵌段共聚物PAM-PGlu-b-TPGS及其制备方法与应用
JP2020512448A (ja) ポリ（オキサゾリン）安定化剤を含有する有機ポリマー粒子および有機ポリマー粒子の安定化のためのポリ（オキサゾリン）の使用
KR100669161B1 (ko) 양친성 공중합체로 제조되는 생분해성 고분자 베지클
KR100987693B1 (ko) 폴리(에틸렌 글리콜)-ｂ-[폴리(Ｌ-세린)-ｇ-폴리(Ｄ,Ｌ-락티드)]의 블록공중합체 및 이를 이용한 약물전달체용 나노입자의 제조 방법
KR100261466B1 (ko) 생분해성나노파티클및이의제조방법
JP2008266631A (ja) 蛋白質結合性高分子とその用途

Legal Events

Date Code Title Description
MA Patent expired